Online Inquiry

tRNA Library Construction

A tRNA library is a designed collection of transfer RNA variants engineered at the anticodon and/or structural identity elements to enable decoding of reassigned codons (e.g., UAG) or quadruplet codons and to interoperate with orthogonal aminoacyl-tRNA synthetases (aaRS). Building on our GCEngine platform, we provide end-to-end tRNA library construction for research-use applications in E. coli, yeast, and mammalian cells, enabling high-fidelity ncAA insertion and site-specific incorporation of ncAAs enabling protein functionalization.

Introduction to tRNA Library

A modern tRNA library is more than anticodon mutants. It typically combines:

  • Codon strategies: amber suppression (UAG), quadruplet decoding, or sense-codon reassignment (as appropriate for the host and use case).
  • Orthogonality by design: tRNAs that are aminoacylated only by their matched orthogonal aaRS, avoiding crosstalk with host aaRS/tRNAs.
  • Scaffold engineering: swapping scaffolds or modifying recognition elements to tune accessibility, transcription, processing, and stability in a given host.
  • Quantitative screening: ratiometric reporters and positive/negative selection to maximize ncAA-dependent readthrough while minimizing leakiness; response-curve/LOD characterization supports ranking at scale.
  • Downstream validation: mass spectrometry confirmation of site-specific incorporation and misincorporation profiling.

Our Services

We offer a Design–Build–Test–Learn workflow that constructs tRNA libraries matched to your codon strategy, host system, and orthogonal aaRS, and then screens them with quantitative reporters to select high-efficiency, low-leak variants ready for protein engineering.

Library Strategy &
In-silico Design

Define the codon strategy (UAG, quadruplet, or targeted sense reassignment) and redesign anticodon and identity elements to enforce orthogonality. Select tRNA scaffolds and regulatory parts per host, and map compatibility to chosen aaRS families and ncAA chemistries.

Library Construction &
Cloning

Construct focused or semi-random libraries using pooled oligos and controlled doping around recognition sites. Assemble sub-pools with Golden Gate/Gibson, apply barcode tagging for deconvolution, and prepare matched expression vectors for aaRS/tRNA co-delivery.

Host Implementation &
Expression Tuning

Introduce libraries into E. coli, yeast, or mammalian cells with defined copy number and expression schemes. Run parameter sweeps (temperature, induction, dosage) to balance aaRS/tRNA expression and stabilize transcription, processing, and tRNA abundance.

Screening & Selection
(Quantitative)

Quantify ncAA-dependent translation with ratiometric reporters and FACS-gated positive/negative selection to suppress leak. Report relative readthrough efficiency, fold induction, and limit-of-detection curves, and deploy counter-screens to penalize misacylation or off-target decoding.

Hit Calling, NGS Mapping & Sequence Analytics

Link genotype to phenotype via barcode-guided enrichment and targeted NGS. Cluster enriched variants, estimate orthogonality and background under control assays,, and prioritize consensus motifs that generalize across hosts or perform best under specified ncAA and codon settings.

Functional Validation &
Analytics

Validate winners using sfGFP-TAG or target constructs and confirm site-specific ncAA incorporation by intact mass and LC-MS/MS. Profile misincorporation, assess expression burden, and, if requested, run functional readouts relevant to the intended protein activity.

Contact Us

Our tRNA library construction service is engineered to deliver accurate, reproducible, and selection-ready libraries, ensuring high-fidelity ncAA incorporation across E. coli, yeast, and mammalian hosts. Let our GCEngine platform be your trusted partner from codon-strategy design through quantitative screening and MS confirmation. Contact us today to discuss your targets and timelines.

Rare Skin Diseases

A specialized platform advancing genetic code expansion through orthogonal tRNA/aaRS technologies, enabling precise ncAA incorporation for biotherapeutic development, synthetic biology, and diagnostics.

Contact Us